2010
DOI: 10.1016/j.sleep.2009.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Assessing the reliability and validity of a newly developed insomnia treatment satisfaction questionnaire (ITSAT-Q)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
5
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 32 publications
1
5
0
Order By: Relevance
“…Additionally, 50% to 67% of their sleep is during night and 54% to 57% happen during daytime. This confirms that both their circadian rhythm and quality of their sleep have been affected ( Beyer et al, 2010 ).…”
Section: Introductionsupporting
confidence: 77%
“…Additionally, 50% to 67% of their sleep is during night and 54% to 57% happen during daytime. This confirms that both their circadian rhythm and quality of their sleep have been affected ( Beyer et al, 2010 ).…”
Section: Introductionsupporting
confidence: 77%
“…Besides being the first instrument to assess TS in patients with chronic HCV, another contribution of this study was the use of SEM to assess the correlation between the TE and the global (exogenous) measure of TS. While global and general measures of TS may not always perform as desired, they are important from the perspective of clinical research for use as a validation measure in comparison with the data obtained from patient history, other instruments and clinical evaluation. Furthermore, instructing patients to consider multiple aspects of their treatment experience when making global ratings might increase the validity of their perceptions if such ratings more adequately characterise patient experiences with their treatment compared with global ratings without such instructions …”
Section: Discussionmentioning
confidence: 99%
“…However, these scales could be limited when capturing all the patient perceptions associated with the special characteristics of treatment employed with certain illnesses, as would be the case in allergic patients undergoing specific immunotherapy treatment. That is probably why quite a few questionnaires have been developed to measure treatment satisfaction specific for certain illnesses and patient populations 412. Yet, how can we assess the specific immunotherapy-treated allergic patient satisfaction, and his/her relation to other basic parameters in the clinical management of this population, without having a suitable instrument available?…”
Section: Discussionmentioning
confidence: 99%
“…The assessment of patient satisfaction with treatment should contemplate these aspects, and should be carried out with duly developed instruments that take into account the patient’s perspective during its development 1–3. Currently, there already exist multidimensional scales that assess treatment satisfaction (referring solely to the medication employed or including other aspects relative to the treatment) regarding different illnesses48 or symptoms 912. There are also more generic instruments, eg, that assess the chronic patient’s treatment satisfaction in general, as is shown in the case of the Treatment Satisfaction Questionnaire for Medication that includes dimensions common to chronic treatments13,14 or other scales 15.…”
Section: Introductionmentioning
confidence: 99%